Navigation Links
New Phase 3 Data Continue to Indicate that Wyeth's Investigational 13-valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease
Date:6/11/2009

s system, inflammation, transplantation, haemophilia, oncology, vaccines and nutritional products.

Wyeth is one of the world's largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing and marketing of pharmaceuticals, vaccines, biotechnology products, nutritionals and non-prescription medicines that improve the quality of life for people worldwide. The Company's major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health.

The statements in this press release that are not historical facts are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. In particular, clinical trial data are subject to differing interpretations, and the views of regulatory agencies, medical and scientific experts and others may differ from ours. There can be no assurance that Prevenar 13 will ever receive regulatory approval or be successfully developed and commercialized. Other risks and uncertainties that could cause actual results to differ materially from those expressed or implied by forward-looking statements include, among others, risks related to our proposed merger with Pfizer, including satisfaction of the conditions of the proposed merger on the proposed timeframe or at all, contractual restrictions on the conduct of our business included in the merger agreement, and the potential for loss of key personnel, disruption in key business activities or any impact on our relationships with third parties as a result of the announcement of the proposed merger; the inherent uncertainty of the timing and success of, and expense associated with, research, development, regulatory approval and commercialization of our products and pipeline products; government cost-containment initiatives; restrictions on third-pa
'/>"/>

SOURCE Wyeth Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
5. Evotec to Present Details of the Positive Phase II Study in Insomnia With EVT 201 at the Worldsleep07 Congress in Cairns/Australia
6. Phase III Trial Finds Pharmaxis Bronchitol Effective
7. YM BioSciences USA cleared by US FDA to initiate Phase II clinical trial of nimotuzumab in children with inoperable, recurrent brain cancer
8. YM BIOSCIENCES ANNOUNCES POSITIVE PRELIMINARY RESULTS FROM PHASE I/II LUNG CANCER TRIAL OF NIMOTUZUMAB COMBINED WITH RADIATION
9. Exelixis Reports Encouraging Interim Data From a Phase 2 Trial of XL647 as First-Line Therapy for Non-Small Cell Lung Cancer
10. Evotec Reports Details of the Positive Proof-of-Concept Phase II Study in Insomnia With EVT 201
11. Stimuvax(R) Phase II data highlight three-year survival results for patients with non-small cell lung cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...FirstCall/ -- Spherix Incorporated (Nasdaq: SPEX ...apy, and a provider of technical and regulatory co...gy and pharmaceutical companies, today announced t...ders. ,, At the meeting, shareholders of Spheri...ing members to the Board of Directors: ,, Doug...
(Date:11/19/2009)...nd recognized refractive and cataract surgery expe...their fellow surgeons up-to-date on the latest dev...urgery, and ophthalmology in general at the recent...O) annual meeting in San Francisco, California. Dr... Huang, MD, Dr. Randy Epstein, Dr. William Trattle...
(Date:11/18/2009)...-- Marrone Bio Innovations (MBI), a leader in the ...fective and environmentally responsible pest manag...n IC20 company by the Investors, Circle, the Unite...ing group. ,, Companies named to the IC20 excel...ll stakeholders, including investors, the environm...
(Date:11/18/2009)... developing new sensors to detect chemical agents ...inst the threat of terrorist attacks. , The devi...dual or crime scene to gather a sample which is th...ct the presence of chemicals within seconds. This ...response to terrorist threats. , The scanning i...
Breaking Biology Technology:Spherix Announces Results of Annual Shareholders Meeting 2Spherix Announces Results of Annual Shareholders Meeting 3Spherix Announces Results of Annual Shareholders Meeting 4Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 2Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 3Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 4Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 5Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 6Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 7Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 8Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 9Marrone Bio Innovations Named an IC20 Company 2New technology detects chemical weapons in seconds 2
...rrently in orbit and the National Aeronautics and ...ram, scientists have been able to observe the Eart...ous disease outbreaks around the world. The use o...edicting the outbreak of some of the most common a... West Nile virus and Rift Valley Fever. The abili...
... of the National Nanotechnology Initiative has jus...ce, Engineering, and Technology (NSET) Subcommitte...Committee on Technology with support from the Nati...The 2007 NNI Strategic Plan describes the vision, ...e United States derives growing economic benefits ...
...hairman of the Board S. Colin ...mos Corporation,(Nasdaq: PARS ) announced today c...ement, effective immediately., Board Changes, Ro...Executive Chairman., Haim Aviv, Ph.D., David Schl...., The Pharmos Board now consists of seven direct...
Other Biology Technology:NASA technology helps predict and prevent future pandemic outbreaks 2National Nanotechnology Initiative releases new strategic plan 2National Nanotechnology Initiative releases new strategic plan 3Pharmos Corporation Announces Board and Management Changes 2Pharmos Corporation Announces Board and Management Changes 3
(Date:11/22/2009)...renatally to tobacco smoke and during childhood to...rding to research done at Cincinnati Children,s Ho...t up to 35 percent of ADHD cases in children betwe...ating both of these environmental exposures. This ...Tobacco and lead exposure each have their own impo...
(Date:11/22/2009)...2009 -- A butterfly,s proboscis looks like a straw...works more like a paper towel, according to Konsta...row the tricks of this piece of insect anatomy to ... of cells. , Kornev will present his work next w...sical Society,s (APS) Division of Fluid Dynamics w...
(Date:11/20/2009)...n many scientific and technological frontiers. The... support that totals nearly $4.3 million for the d...r the American Recovery and Reinvestment Act of 20...s for investigation of solar phenomena. Philip R. ...hance the capabilities of NJIT,s Big Bear Solar Ob...
Breaking Biology News(10 mins):Exposure to lead, tobacco smoke raises risk of ADHD 2NJIT receives NSF funding to improve Big Bear Telescope, study solar energy 2Researchers Find Common Respiratory Virus Hijacks Lung Cells to Stay Alive 4946 1Researchers Find Common Respiratory Virus Hijacks Lung Cells to Stay Alive 4946 2Researchers Find Common Respiratory Virus Hijacks Lung Cells to Stay Alive 4946 3Young Animals May Be Able to Erase Bad Memories 56289 1Young Animals May Be Able to Erase Bad Memories 56289 2Newly Formed American Society for Nanomedicine 28ASNM 29 to Hold First Conference 28www amsocnanomed org 29 56285 1Newly Formed American Society for Nanomedicine 28ASNM 29 to Hold First Conference 28www amsocnanomed org 29 56285 2
...idens. Called granulosa cells, they surround eggs ...osa cells, eggs cannot mature and be successfully ...gists at Brown University and the University of Ca...s ?TAF4b and c-Jun ?team up to turn on about two d...his subset of genes, in turn, writes the genetic c...
...k fish" and fishermen,s nets will be hauling in ev...on to stem the global tide of over fishing, says a...sh Columbia. Dr. Daniel Pauly says the crisis in t...f than about attitude and political will. , And, ...file political champion like a Bono or Mandela to ...
...t wildlife biologists have with wolverines in the ...tracks in the snow. But wildlife biologist Keith A...ted for several weeks. , A member of his research...ade Range of Washington to report that a wolverine... and research wildlife biologist at the U.S. Fores...
Other Biology News:A surprising pair of proteins help make healthy eggs 2Hooked on fishing, and we're heading for the bottom, says scientist 2Hooked on fishing, and we're heading for the bottom, says scientist 3First wolverine radio-collared in Pacific Northwest 2
Anti-S-100 protein, ab heterodimer Monoclonal Antibody, Unconjugated from HyTest Ltd.
... deep experience, skills and flexibility in produc...ive team chemistry. This combination enables optim... and beyond.,With AAIBiotech, you can count o...et more than that: its the power of team chemistry...
... aa 16-25 of human GSK3 alpha. Immunogen: Synt...at -20 C prior to opening. Dilute only prior to i...s and freeze at -20 C or below. Avoid cycles of f...ly: not assigned-Other Applications: ELISA Wr...
UNOsphere S Support, 100 ml from Bio-Rad
Biology Products: